Clinical Trial Update: BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, pharmacokinetics (PK) and pharmacodynamics (PD) of dapagliflozin in individuals with Type 1 Diabetes Mellitus. The trial is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2017-02-10